Following Its 52-Week Low, Cross Country Healthcares, Inc. (NASDAQ: CCRN)’S Share Price Rose 8.64% And Its YTD Numbers Fell -24.34%

During the last session, Cross Country Healthcares, Inc. (NASDAQ:CCRN)’s traded shares were 2.08 million, with the beta value of the company hitting 0.75. At the end of the trading day, the stock’s price was $17.13, reflecting an intraday gain of 1.60% or $0.27. The 52-week high for the CCRN share is $28.75, that puts it down -67.83 from that peak though still a striking 8.64% gain since the share price plummeted to a 52-week low of $15.65. The company’s market capitalization is $594.92M, and the average intraday trading volume over the past 10 days was 0.34 million shares, and the average trade volume was 507.64K shares over the past three months.

Cross Country Healthcares, Inc. (NASDAQ:CCRN) trade information

Cross Country Healthcares, Inc. (CCRN) registered a 1.60% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.60% in intraday trading to $17.13, hitting a weekly high. The stock’s 5-day price performance is -9.51%, and it has moved by -15.70% in 30 days. Based on these gigs, the overall price performance for the year is -26.83%. The short interest in Cross Country Healthcares, Inc. (NASDAQ:CCRN) is 5.38 million shares and it means that shorts have 6.89 day(s) to cover.

Cross Country Healthcares, Inc. (CCRN) estimates and forecasts

Statistics show that Cross Country Healthcares, Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Cross Country Healthcares, Inc. (CCRN) shares have gone down -28.89% during the last six months, with a year-to-date growth rate less than the industry average at -57.40% against -23.40. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -79.80% this quarter and then drop -72.50% in the quarter after that. In the rating firms’ projections, revenue will decrease -26.60% compared to the previous financial year.

Revenue for the current quarter is expected to be $374.09 million as predicted by 8 analyst(s). Meanwhile, a consensus of 8 analyst(s) estimates revenue growth to $363.26 million by the end of Jun 2024. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $595 million and $531.68 million respectively. In this case, analysts expect current quarter sales to shrink by -37.10% and then drop by -31.70% in the coming quarter.

While earnings are projected to return -57.68% in 2024, the next five years will return 10.00% per annum.

CCRN Dividends

Cross Country Healthcares, Inc. is due to release its next quarterly earnings between May 01 and May 06. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Cross Country Healthcares, Inc. (NASDAQ:CCRN)’s Major holders

Cross Country Healthcares, Inc. insiders own 5.55% of total outstanding shares while institutional holders control 111.12%, with the float percentage being 117.65%. Blackrock Inc. is the largest shareholder of the company, while 271 institutions own stock in it. As of Jun 29, 2023, the company held over 5.6 million shares (or 15.64% of all shares), a total value of $157.25 million in shares.

The next largest institutional holding, with 2.46 million shares, is of Vanguard Group Inc’s that is approximately 6.88% of outstanding shares. At the market price on Jun 29, 2023, these shares were valued at $69.21 million.

Also, the Mutual Funds coming in first place with the largest holdings of Cross Country Healthcares, Inc. (CCRN) shares are iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund. Data provided on Sep 29, 2023 indicates that iShares Core S&P Smallcap ETF owns about 2.27 million shares. This amounts to just over 6.35 percent of the company’s overall shares, with a $56.33 million market value. The same data shows that the other fund manager holds slightly less at 1.09 million, or about 3.04% of the stock, which is worth about $30.55 million.